Skip to main content
British Medical Journal logoLink to British Medical Journal
. 1978 Dec 16;2(6153):1673–1674. doi: 10.1136/bmj.2.6153.1673

Treatment and survival on advanced breast cancer.

T Priestman, M Baum, V Jones, J Forbes
PMCID: PMC1608971  PMID: 367510

Abstract

The final results of a clinical trial comparing endocrine with cytotoxic drug treatment for advanced breast cancer were analysed. Although cytotoxic treatment gave a significantly higher response rate with a remission duration comparable to that obtained with endocrine treatment, the sequence in which the two treatments were given did not appear to influence survival--except possibly in women with rapidly progressing disease, when cytotoxic treatment is preferred.

Full text

PDF
1673

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Leclercq G., Heuson J. C. Therapeutic significance of sex-steroid hormone receptors in the treatment of breast cancer. Eur J Cancer. 1977 Nov;13(11):1205–1215. doi: 10.1016/0014-2964(77)90026-3. [DOI] [PubMed] [Google Scholar]
  2. Priestman T., Baum M., Jones V., Forbes J. Comparative trial of endocrine versus cytotoxic treatment in advanced breast cancer. Br Med J. 1977 May 14;1(6071):1248–1250. doi: 10.1136/bmj.1.6071.1248. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES